Because GNAS mutations are speculated to participate in upregulating MEG3 expression, the expression levels of MEG3 in NFPA and GHPA tumor tissues were quantified via RT-qPCR. The gene discussed is GNAS; the disease is non-functioning pituitary adenoma.